Does MOBOCERTINIB Cause Product dose omission issue? 42 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 42 reports of Product dose omission issue have been filed in association with MOBOCERTINIB. This represents 5.9% of all adverse event reports for MOBOCERTINIB.
42
Reports of Product dose omission issue with MOBOCERTINIB
5.9%
of all MOBOCERTINIB reports
11
Deaths
24
Hospitalizations
How Dangerous Is Product dose omission issue From MOBOCERTINIB?
Of the 42 reports, 11 (26.2%) resulted in death, 24 (57.1%) required hospitalization.
Is Product dose omission issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for MOBOCERTINIB. However, 42 reports have been filed with the FAERS database.
What Other Side Effects Does MOBOCERTINIB Cause?
Diarrhoea (309)
Death (160)
Rash (106)
Non-small cell lung cancer (96)
Nausea (85)
Decreased appetite (80)
Lung neoplasm malignant (74)
Vomiting (74)
Fatigue (66)
Asthenia (56)
What Other Drugs Cause Product dose omission issue?
DUPILUMAB (18,189)
USTEKINUMAB (9,405)
GUSELKUMAB (9,267)
LENALIDOMIDE (8,145)
MEPOLIZUMAB (5,873)
TOFACITINIB (5,646)
VOXELOTOR (5,122)
BELIMUMAB (4,671)
SECUKINUMAB (4,572)
APREMILAST (4,460)
Which MOBOCERTINIB Alternatives Have Lower Product dose omission issue Risk?
MOBOCERTINIB vs MOCLOBEMIDE
MOBOCERTINIB vs MODAFINIL
MOBOCERTINIB vs MOGAMULIZUMAB
MOBOCERTINIB vs MOGAMULIZUMAB-KPKC
MOBOCERTINIB vs MOLNUPIRAVIR